Boston Scientific (BSX) FCF Margin Growth (1y) (2010 - 2026)
Boston Scientific (BSX) FCF Margin Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 157.80 Bn | 151.14 Bn | 6.27 Bn | -80.00 |
| 2 | Stryker | 115.54 Bn | 112.66 Bn | 3.81 Bn | 473.00 |
| 3 | Medtronic | 103.44 Bn | 95.27 Bn | 5.76 Bn | 23.00 |
| 4 | Boston Scientific | 72.38 Bn | 71.17 Bn | 3.61 Bn | -431.00 |
| 5 | Edwards Lifesciences | 49.76 Bn | 46.09 Bn | 1.29 Bn | -1,716.00 |
| 6 | Dexcom | 29.53 Bn | 28.42 Bn | 750.30 Mn | 2,833.00 |
| 7 | GE HealthCare Technologies | 29.51 Bn | 27.44 Bn | 1.98 Bn | 192.00 |
| 8 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2,811.00 |
| 9 | Steris | 20.69 Bn | 20.27 Bn | 697.10 Mn | 261.00 |
| 10 | Zimmer Biomet Holdings | 17.04 Bn | 16.63 Bn | 1.51 Bn | -223.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -431.00 |
| Dec 31, 2025 | -669.00 |
| Sep 30, 2025 | 339.00 |
| Jun 30, 2025 | 634.00 |
| Mar 31, 2025 | 798.00 |
| Dec 31, 2024 | 733.00 |
| Sep 30, 2024 | 515.00 |
| Jun 30, 2024 | 166.00 |
| Mar 31, 2024 | -272.00 |
| Dec 31, 2023 | 17.00 |
| Sep 30, 2023 | 431.00 |
| Jun 30, 2023 | 808.00 |
| Mar 31, 2023 | 825.00 |
| Dec 31, 2022 | 1,157.00 |
| Sep 30, 2022 | -212.00 |
| Jun 30, 2022 | -1,123.00 |
| Mar 31, 2022 | -1,351.00 |
| Dec 31, 2021 | -1,219.00 |
| Sep 30, 2021 | -1,013.00 |
| Jun 30, 2021 | 742.00 |